Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale‐29

por Rosti‐Otajärvi, Eija, Hämäläinen, Päivi, Wiksten, Anna, Hakkarainen, Tanja, Ruutiainen, Juhani
Publicado 2017

Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients

por Rosti‐Otajärvi, Eija, Hämäläinen, Päivi, Wiksten, Anna, Hakkarainen, Tanja, Ruutiainen, Juhani
Publicado 2017

Estimating relative efficacy in acute postoperative pain: network meta-analysis is consistent with indirect comparison to placebo alone

por Moore, R. Andrew, Derry, Sheena, Wiffen, Philip J., Banerjee, Samik, Karan, Rajesh, Glimm, Ekkehard, Wiksten, Anna, Aldington, Dominic, Eccleston, Christopher
Publicado 2018

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Stu...

por Deodhar, Atul, Blanco, Ricardo, Dokoupilová, Eva, Hall, Stephen, Kameda, Hideto, Kivitz, Alan J., Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S., Porter, Brian O., Richards, Hanno B., Haemmerle, Sibylle, Braun, Jürgen
Publicado 2020

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

por Braun, Jürgen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S., van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S., Porter, Brian O., Shete, Abhijit, Richards, Hanno B., Haemmerle, Sibylle, Deodhar, Atul
Publicado 2021